JNBCX | VSCGX | JNBCX / VSCGX | |
Total Expense Ratio | 1.25 | 0.12 | 1,042% |
Annual Report Gross Expense Ratio | 1.57 | 0.12 | 1,308% |
Fund Existence | 18 years | 31 years | - |
Gain YTD | 7.561 | 7.162 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 10.5B | 79% |
Annual Yield % from dividends | 5.14 | 3.03 | 170% |
Returns for 1 year | 10.47 | 5.63 | 186% |
Returns for 3 years | 22.36 | 14.51 | 154% |
Returns for 5 years | 20.91 | 9.13 | 229% |
Returns for 10 years | 44.15 | 37.31 | 118% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ACSCX | 9.94 | 0.06 | +0.61% |
American Century Small Cap Value A | |||
VTSMX | 152.62 | 0.67 | +0.44% |
Vanguard Total Stock Mkt Idx Inv | |||
GILLX | 23.90 | 0.10 | +0.42% |
Goldman Sachs Enhanced U.S. Equity Inst | |||
HFSSX | 16.06 | 0.06 | +0.37% |
Hartford Schroders Intl Cntrrn Val SDR | |||
FBTIX | 30.97 | N/A | N/A |
Fidelity Advisor Biotechnology I |